Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 270.3K | 241.5K | 301.2K | 277.2K |
Selling general and admin | 61.2K | 51.3K | 51.1K | 92.6K |
Other operating expenses | — | — | — | — |
Operating income | -331.5K | -292.8K | -352.2K | -369.8K |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -331.5K | -292.8K | -352.2K | -369.8K |
Tax provision | 0 | — | 0 | 0 |
Net income | -331.5K | -292.8K | -352.2K | -369.8K |
Basic EPS | 0 | — | 0 | 0.0 |
Diluted EPS | 0 | — | 0 | 0.0 |
Basic average shares | 131.4M | — | 131.4M | 131.4M |
Diluted average shares | 131.4M | — | 131.4M | 131.4M |
EBITDA | -331.5K | -292.8K | -352.2K | -369.8K |
Net income from continuing op. | -331.5K | -292.8K | -352.2K | -369.8K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |